Overview
Availability
- Dr Yasuko Koda is:
- Available for supervision
Qualifications
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Yasuko Koda’s works on UQ eSpace
2025
Journal Article
Synthesis and Investigation of Peptide-Drug Conjugates Comprising Camptothecin and a Human Protein-Derived Cell-Penetrating Peptide
Palombi, Isabella R., White, Andrew M., Koda, Yasuko, Craik, David J., Lawrence, Nicole and Malins, Lara R. (2025). Synthesis and Investigation of Peptide-Drug Conjugates Comprising Camptothecin and a Human Protein-Derived Cell-Penetrating Peptide. Chemical Biology & Drug Design, 105 (1) e70051, 1-10. doi: 10.1111/cbdd.70051
2025
Journal Article
Analogs of cyclic peptide mortiamide‐d from marine fungi have improved membrane permeability and kill drug‐resistant melanoma cells
Bergeron, Catherine, Bérubé, Christopher, Lamb, Henry, Koda, Yasuko, Craik, David J., Henriques, Sónia Troeira, Voyer, Normand and Lawrence, Nicole (2025). Analogs of cyclic peptide mortiamide‐d from marine fungi have improved membrane permeability and kill drug‐resistant melanoma cells. Peptide Science, 117 (1) e24380. doi: 10.1002/pep2.24380
2022
Journal Article
Design and synthesis of tranylcypromine-derived LSD1 inhibitors with improved hERG and microsomal stability profiles
Koda, Yasuko, Sato, Shin, Yamamoto, Hirofumi, Niwa, Hideaki, Watanabe, Hisami, Watanabe, Chiduru, Sato, Tomohiro, Nakamura, Kana, Tanaka, Akiko, Shirouzu, Mikako, Honma, Teruki, Fukami, Takehiro, Koyama, Hiroo and Umehara, Takashi (2022). Design and synthesis of tranylcypromine-derived LSD1 inhibitors with improved hERG and microsomal stability profiles. ACS Medicinal Chemistry Letters, 13 (5), 848-854. doi: 10.1021/acsmedchemlett.2c00120
2008
Journal Article
In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue
Koda, Y., Liang, M., Blanchfield, J. T. and Toth, I. (2008). In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue. International Journal of Pharmaceutics, 356 (1-2), 37-43. doi: 10.1016/j.ijpharm.2007.12.036
2008
Conference Publication
Solute and vehicle lipophilicity effects on solute maximum flux through human epidermal membranes
Koda, Y., Cross, S. E., Grice, J. E., Jepps, O. G. and Roberts, M. S. (2008). Solute and vehicle lipophilicity effects on solute maximum flux through human epidermal membranes. Perspectives in Percutaneous Penetration Eleventh Annual Conference, La Grande Motte, France, 29 March, 2008.
2008
Journal Article
Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides
Koda, Y., Del Borgo, M., Wessling, S., Lazarus, L. H., Okada, Y., Toth, I. and Blanchfield, J. T. (2008). Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. Bioorganic & Medicinal Chemistry, 16 (11), 6286-6296. doi: 10.1016/j.bmc.2008.04.020
2007
Journal Article
Caco-2 cell permeability and stability of two D-glucopyranuronamide conjugates of thyrotropin-releasing hormone
Wessling, Susanne T., Ross, Benjamin P., Koda, Yasuko, Blanchfield, Joanne T. and Toth, Istvan (2007). Caco-2 cell permeability and stability of two D-glucopyranuronamide conjugates of thyrotropin-releasing hormone. Bioorganic & Medicinal Chemistry, 15 (14), 4946-4950. doi: 10.1016/j.bmc.2007.04.042
2007
Journal Article
Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide
Koda, Y., Shiotani, K., Toth, I., Tsuda, Y., Okada, Y. and Blanchfield, J. (2007). Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide. Bioorganic & Medicinal Chemistry Letters, 17 (7), 2043-2046. doi: 10.1016/j.bmcl.2007.01.051
2007
Other Outputs
A novel liposaccharide system for the delivery of endomorphin-1 across the blood-brain barrier
Koda, Yasuko (2007). A novel liposaccharide system for the delivery of endomorphin-1 across the blood-brain barrier. PhD Thesis, School of Pharmacy, The University of Queensland. doi: 10.14264/158354
2007
Journal Article
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase
Kim, I., Nishi, I., Tsai, H., Bradford, T., Koda, Y., Watanabe, T., Morriseau, C., Blanchfield, J., Toth, I. and Hammock, B. (2007). Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry, 15 (1), 312-323. doi: 10.1016/j.bmc.2006.09.057
2006
Conference Publication
Liposaccharides in peptide, gene and vaccine delivery
Toth, I., Moyle, P. M., Koda, Y., Olive, C. and Good, M. F. (2006). Liposaccharides in peptide, gene and vaccine delivery. 33rd Annual Meeting and Exposition of the Controlled Release Soy, Vienna, 22-26 July, 2006.
2006
Journal Article
Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the Caco-2 cell monolayer system
Wu, S., Christopher, C., Koda, Y., Blanchfield, J. T. and Toth, I. (2006). Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the Caco-2 cell monolayer system. Medicinal Chemistry, 2 (2), 203-211. doi: 10.2174/157340606776056205
2004
Conference Publication
Liposaccharides in peptide drug delivery
Blanchfield, J. T., Gallagher, O. P., Koda, Y., Alewood, P.F., Lewis, R. J. and Toth, I. (2004). Liposaccharides in peptide drug delivery. 18th American Peptide Symposium, Boston, 19-23 July, 2003. WASHINGTON: AMER CHEMICAL SOC.
Supervision
Availability
- Dr Yasuko Koda is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Dr Yasuko Koda's areas of expertise, story ideas and help finding experts, contact our Media team: